hit counter

Schizophrenia MRI Subtypes Split 3,958 Patients Into 2 Patterns

MHD featured image for schizophrenia MRI cortical-gradient subtypes.

A 2026 ENIGMA structural MRI preprint involving 3,958 people diagnosed with schizophrenia and 5,489 controls found 2 cortical-alteration subtypes rather than 1 uniform brain pattern.1 The result maps heterogeneity: anterior-cingulate and temporoparietal network patterns may separate patients, but the result is not a diagnostic MRI test. Research Highlights Large MRI base: The analysis included 3,958 …

Read more

Catatonia Brain Circuits: Limbic System Review

MHD featured image for catatonia, limbic-system brain circuits, and psychomotor shutdown.

A 2026 systematic review argues that catatonia should be read as a limbic-cortical circuit syndrome, with motor shutdown tied to brain systems for threat, salience, motivation, and emotional regulation. Research Highlights 20 studies met criteria: the 2026 review screened 1,792 records, assessed 54 full texts, and included 20 articles: 13 observational studies and 7 case …

Read more

Alzheimer’s Progression AI Model Reaches 0.965 mAUC in TADPOLE Dataset

Editorial card showing Alzheimer progression prediction with longitudinal brain scans, model uncertainty, and TADPOLE cohort data.

A 2026 TADPOLE modeling study reported that a sequential neural process with normalizing flows predicted future Alzheimer diagnostic stage with mAUC 0.965 ± 0.006, ahead of the authors’ earlier sequential-neural-process model at 0.937 ± 0.014.1 The result is a strong benchmark signal for uncertainty-aware disease-progression AI, but it is still retrospective modeling evidence rather than …

Read more

Psychiatric Brain Biomarkers Lack Clinical Use: 441-Study Map

Psychiatric brain biomarkers have produced a large research literature but little routine clinical use. A 2026 evidence map found 441 primary studies and 27 systematic reviews of neuroimaging or neurophysiologic biomarkers for mental-health disorders, yet the field still looks too small, cross-sectional, and depression-heavy for ordinary diagnostic or treatment decisions.1 Research Highlights Large map, weak …

Read more

Alzheimer’s AI MRI Diagnosis: ANA-GNN Reaches 85.23% Accuracy in ADNI

MHD featured image for ANA-GNN Alzheimer's AI MRI diagnosis in the ADNI cohort.

A 2026 ADNI study reported 85.23% accuracy for ANA-GNN, a graph neural network that combined structural MRI regional features with clinical variables to classify cognitively normal controls, mild cognitive impairment, and Alzheimer’s disease.1 The result is useful, but the clinical-feature ablation dropped accuracy to 68.35%, so the model should be read as multimodal decision-support research, …

Read more

Dynamic FDG-PET Signal Quality Beats Static PET in Focal Epilepsy

MHD featured image for dynamic FDG-PET signal quality in focal epilepsy neuroimaging.

A 2026 medRxiv study of 30 adults with drug-resistant focal epilepsy found that dynamic FDG-PET had higher model-adjusted signal quality than static PET in most brain regions, including >80% posterior probability of superiority in 29 of 36 regions. Research Highlights Dynamic PET beat static PET: interictal dynamic FDG-PET showed higher signal quality than static PET …

Read more

Striatal Dopamine Drops From Psychosis to Schizophrenia Remission

Photoreal illustration of a brain with the striatum highlighted and dopamine synthesis pathways visualized, representing longitudinal PET imaging in schizophrenia.

The dopamine hypothesis of schizophrenia is the field’s longest-running mechanistic story, and most of its supporting evidence has been cross-sectional. A 2026 longitudinal PET study by Schulz and colleagues followed the same 28 patients across psychosis and early remission.1 Research Highlights The dopamine hypothesis of schizophrenia is the field’s longest-running mechanistic story. Cross-sectional 18F-DOPA PET …

Read more